Sign in
Taking peopleNo phase

Memory test stations in pharmacies to spot early memory problems in older adults

Studies pharmacy memory tests for finding mild cognitive impairment or mild dementia in older people.

Key facts

Who runs it
Ludwig-Maximilians - University of Munich
Where
Germany1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Dementia-friendly Apothecaries as a Resource for Mental Heath in the Elderly
Status
Recruiting
People taking part
1,020 people, planned
Started
1 Jul 2025
Expected to end
31 Jul 2027
Type of study
Observational
Record updated
1 April 2026

Who can take part

The trial is looking for people aged 60 or older with memory problems or mild thinking changes, noticed in pharmacies. They take a digital memory test at the pharmacy.

Age
60 Years to 90 Years
Sex
All
Disease stage
Memory problems or mild thinking changes, noticed by the person, a relative or pharmacy staff.
Main reasons for not taking part
  • A past formal diagnosis of dementia
  • Unable to see or hear well enough to do the digital tests or questionnaires
  • Severe thinking or physical problems that prevent taking part in the tests
  • Not enough German to understand the instructions
  • Unable to give consent on your own
Show the full registry criteria (7)Hide the full registry criteria

Who can take part

  • Age: Participants must be 60 years or older at the time of consent
  • Language Proficiency: Sufficient knowledge of the German language to understand instructions and participate in the study
  • Cognitive Status: Presence of self-reported, relative-reported, or pharmacist-identified cognitive impairments (e.g., memory problems or mild cognitive changes)
  • Consent: Ability to provide informed consent voluntarily

Who cannot take part

  • Previous Dementia Diagnosis: Individuals with a prior formal diagnosis of dementia, whether with or without underlying pathology
  • Severe Cognitive or Physical Impairments: Any condition that would prevent meaningful participation in the digital tests or structured screening process; These criteria aim to ensure that the study includes participants at risk of early cognitive decline while excluding those for whom the interventions or assessments would not be feasible or relevant
  • Severe Sensory Impairments: Participants unable to see or hear well enough to complete the digital assessments or questionnaires

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Mild cognitive impairment or mild dementia

This trial is currently available in Germany.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The DARE study (Dementia-Friendly Apothecaries as a Resource for Mental Health in the Elderly) is a multicenter, prospective cohort study aiming to identify individuals with cognitive impairments early in pharmacies and enhance their access to support services. Partner pharmacies are equipped with memory test stations, and pharmaceutical staff are trained to guide participants. The digital memory test evaluates cognitive, psychosocial, and health factors, displaying results in a traffic light graphic. Participants with concerning results are referred to specialists or support services.

Read full original descriptionShow less

The study's primary goals are to establish pharmacies as dementia screening hubs, improve care for affected individuals, promote interdisciplinary collaboration, and lay the groundwork for legal and billing frameworks. An optional subproject validates the screening through neurological evaluations.

The group in the trial

  • prospective cohort study

    The study cohort for the DARE project includes customers and patients from pharmacies located in both urban and rural areas. These participants represent a diverse population segment, including individuals who might not regularly access traditional healthcare services, particularly in rural regions where medical facilities are less accessible. Cohort Details: 1. Eligibility Criteria: * Age: 60 years and older. * Cognitive impairments noted by participants themselves, relatives, or pharmacy staff. * Sufficient understanding of the German language. 2. Inclusion Focus: * Individuals with early cognitive symptoms or mild dementia. * Those potentially underserved by conventional healthcare systems, such as isolated or single individuals.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Demenz-freundliche Apotheken Als Ressource für Psychische Gesundheit im Alter
Plain-language title
Memory test stations in pharmacies to spot early memory problems in older adultsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07504965, who can take part
Record updated
1 April 2026